Primary Poorly Differentiated Squamous Cell Carcinoma of the Extrahepatic Bile Duct

Intern Med. 2016;55(12):1581-4. doi: 10.2169/internalmedicine.55.6226. Epub 2016 Jun 15.

Abstract

Squamous cell carcinoma of the extrahepatic bile duct is quite rare. A 77-year-old woman with jaundice and general fatigue was referred to our hospital. Multiphase contrast-enhanced computed tomography visualized a 17-mm solid mass in the junction of the cystic and common bile ducts. The patient underwent pylorus-preserving pancreaticoduodenectomy. The pathological findings demonstrated keratin-positive poorly differentiated squamous cell carcinoma of the extrahepatic bile duct (T3N0M0, stage IIIA). Although adjuvant chemotherapy with gemcitabine was administered, the patient exhibited local recurrence at the site of anastomosis of biliojejunostomy 20 months after resection and died 32 months after resection.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bile Duct Neoplasms / diagnostic imaging*
  • Bile Duct Neoplasms / drug therapy
  • Bile Duct Neoplasms / pathology*
  • Bile Ducts, Extrahepatic / diagnostic imaging*
  • Bile Ducts, Extrahepatic / pathology*
  • Carcinoma, Squamous Cell / diagnostic imaging*
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / pathology*
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Female
  • Gemcitabine
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / pathology

Substances

  • Deoxycytidine
  • Gemcitabine